WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 6, 2008, 28(6):1452-1459; doi:10.1523/JNEUROSCI.3253-07.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Q.
Right arrow Articles by Huang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Q.
Right arrow Articles by Huang, Y.

 Previous Article  |  Next Article 

Neurobiology of Disease
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS

Qin Xu,1,2 David Walker,1 Aubrey Bernardo,1 Jens Brodbeck,1,2 Maureen E. Balestra,1 and Yadong Huang1,2,3,4

1Gladstone Institute of Neurological Disease and 2Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, and Departments of 3Pathology and 4Neurology, University of California, San Francisco, California 94143

Correspondence should be addressed to Dr. Yadong Huang, Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158. Email: yhuang{at}gladstone.ucsf.edu

Neuronal expression of apolipoprotein (apo) E4 may contribute to the pathogenesis of Alzheimer's disease (AD). In studying how apoE expression is regulated in neurons, we identified a splicing variant of apoE mRNA with intron-3 retention (apoE-I3). ApoE-I3 mRNA was detected in neuronal cell lines and primary neurons, but not in astrocytic cell lines or primary astrocytes, from humans and mice by reverse transcription (RT)-PCR. In both wild-type and human apoE knock-in mice, apoE-I3 was found predominantly in cortical and hippocampal neurons by in situ hybridization. Cell fractionation and quantitative RT-PCR revealed that over 98% of the apoE-I3 mRNA was retained in the nucleus without protein translation. In transfected primary neurons, apoE expression increased dramatically when intron-3 was deleted from a genomic DNA construct and decreased markedly when intron-3 was inserted into a cDNA construct, suggesting that intron-3 retention/splicing controls apoE expression in neurons. In response to excitotoxic challenge, the apoE-I3 mRNA was markedly increased in morphologically normal hippocampal neurons but reduced in degenerating hippocampal neurons in mice; apoE mRNA showed the opposite pattern. This apparent precursor–product relationship between apoE-I3 and apoE mRNA was supported by a transcriptional inhibition study. Thus, neuronal expression of apoE is controlled by transcription of apoE-I3 under normal conditions and by processing of apoE-I3 into mature apoE mRNA in response to injury.

Key words: apolipoprotein E; Alzheimer's disease; excitotoxicity; gene regulation; intron retention; knock-in mice


Received April 17, 2007; revised Nov. 7, 2007; accepted Dec. 15, 2007.

Correspondence should be addressed to Dr. Yadong Huang, Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158. Email: yhuang{at}gladstone.ucsf.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. S. Seelan, J. Lakshmanan, M. F. Casanova, and R. N. Parthasarathy
Identification of myo-Inositol-3-phosphate Synthase Isoforms: CHARACTERIZATION, EXPRESSION, AND PUTATIVE ROLE OF A 16-kDa {gamma}c ISOFORM
J. Biol. Chem., April 3, 2009; 284(14): 9443 - 9457.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
J. Lipid Res., April 1, 2009; 50(Supplement): S183 - S188.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Agosta, K. A. Vossel, B. L. Miller, R. Migliaccio, S. J. Bonasera, M. Filippi, A. L. Boxer, A. Karydas, K. L. Possin, and M. L. Gorno-Tempini
Apolipoprotein E {varepsilon}4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia
PNAS, February 10, 2009; 106(6): 2018 - 2022.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Yue, T. A. Ponzio, R. L. Fields, and H. Gainer
Oxytocin and vasopressin gene expression and RNA splicing patterns in the rat supraoptic nucleus
Physiol Genomics, November 12, 2008; 35(3): 231 - 242.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-